Esmeralda is the CEO and co-founder of Xsensio, a Swiss deeptech / digital health company focused on solving one of the biggest challenges in healthcare: the lack of real-time, continuous monitoring of relevant health parameters to take better healthcare decisions. Her world-class team is developing the breakthrough Lab-on-Skinc wearable platform, to move the diagnostics field from a static approach today (single point lab tests) to a dynamic one tomorrow to detect short term proteins and hormones changes on time during critical health events.
Prior to Xsensio, Esmeralda had several years of experience as manager at Boston-based investment firm Commons Capital where she was in charge of screening investment opportunities in a partnership with the Bill and Melinda Gates Foundation. She earned her MBA at the Massachusetts Institute of Technology (MIT), a B.S. and M.S. in Economics from ULB, Belgium and an executive degree in management from EPFL in Switzerland.